Legislation

Michael Needham, principal at Efficio, says the Trump administration's tariffs create uncertainty and indecision for business.  

The organization is seeking feedback on how to best advance digital health to empower seniors using technology, while reducing administrative burdens and improving interoperability.

The Health Tech Investment Act would establish a reimbursement pathway for FDA-cleared AI-enabled medical devices. 

Leaders of government public policy at HIMSS are prioritizing health equity, AI regulation, cybersecurity and workforce development while urging unified policies that support healthcare innovation.

The bill would allow AI to be classified as a "practitioner licensed by law" to administer FDA-approved drugs.

Ashkan Afkhami of BCG X sat down with MobiHealthNews during JPM to discuss the U.S. health system's strengths, challenges in cost control and the transformative potential of AI.

President Trump revoked Joe Biden's 2023 order, which required HHS to establish an AI safety program and developers to share test results, among other directives.

At an event outside JPM, which included a representative from HHS, panelists discussed the government's role in advancing AI and the evolving healthcare landscape as a new administration transitions into power.